Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization ...
Knowing which stem cell characteristics to optimize during the manufacturing process is among the biggest challenges still facing the cell therapy industry. That’s according to Greg Fiore, MD, CEO of ...
What could be the most advanced attempt to bring stem cell treatments to the market could start any day now in Orange County. NeoStem Inc. said last week that the Food and Drug Branch of the ...
CellProthera will use Quintessence’s DACSTM flotation‑based cell sorting platform for its potential to enhance therapeutic purity and preserve stem cell phenotype for CD34+-based cell therapy Mulhouse ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford ...
The success of stem cell therapies has been some time in coming, explains Michael Jacobson, PhD, founding partner at Cambridge Biostrategy Associates. “Stem cells—specifically Mesenchymal Stem Cells ...
The stem cell therapy market is witnessing strong growth driven by rising demand for regenerative medicine and advanced treatment options for chronic diseases such as cancer, diabetes, and ...
Collaboration with Stanford Medicine establishes a platform manufacturing process and analytics designed to support gene-edited hematopoietic stem cell therapies for HIV and more than 19 rare diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results